I would like to invite you to attend the 14th Immunology of Diabetes Society Congress in Munich from April 12 to 16, 2015.
Anette-Gabriele Ziegler, Institute of Diabetes Research, Helmholtz Zentrum München; Klinikum rechts der Isar, Technische Universität München
Carolin Daniel, Institute of Diabetes Research, Junior Research Group Immune Tolerance in Type 1 Diabetes, Helmholtz Zentrum München
Lydia Henneberger (Assistant), Klinikum rechts der Isar, Technische Universität München
Local Program Committee:
Anette-Gabriele Ziegler, Carolin Daniel, Ezio Bonifacio, Karsten Kretschmer, Peter Achenbach
The IDS is challenged by the increasing number of children with type 1 diabetes worldwide, an autoimmune disease that can occur at any age, and our limited ability to change its course once autoimmunity has started. We are in exciting times with an unprecedented ability to generate data together, and this calls for us to see, hear, and discuss the data openly, critically, and constructively. This is the spirit of IDS 2015. We will bring together the experts, the data, those who think the same, those who think differently, and those who fund us to find the cause and the cure. Most of all, we want all of you who contribute to changing the course of autoimmune diabetes to be at the IDS in Munich, where we hope the relaxed Bavarian atmosphere will help us all achieve this. Together, we will be looking at what leads to islet autoimmunity in children, the biomarkers that stage checkpoints of disease development and intervention, what goes on inside the pancreas, and how we are and should be intervening to change the course of disease.
Please join us in a meeting of discovery and collaboration in the cause, prevention, and cure of type 1 diabetes.
With warm regards,
Prof. Dr. Anette-Gabriele Ziegler
Congress President IDS 2015
The Immunology of Diabetes Society (IDS) is a scientific society dedicated to improving understanding and treatment of type 1 diabetes. IDS organizes a Congress every 18 months at which there are scientific presentations to further this goal. IDS entered into an agreement with the conferences division of Elsevier to act as conference organizer for the 14th IDS Congress in Munich in 2015. Subsequently, a controversy has developed over a letter in July in The Lancet, an Elsevier publication, about the situation in Gaza. Regrettably, the controversy is ongoing.
The IDS Council wishes to inform its members that the arrangement with Elsevier to organize the IDS Congress is solely to facilitate the Congress and to increase and disseminate knowledge about the immunology of diabetes. This arrangement should not be interpreted as support for or endorsement of Elsevier’s activities more broadly.